Cerulea Clinical Trials

Close Menu
Close Close

Clinical Trials

ADVISE

Adalimumab vs. Conventional Immunosuppression for Corticosteroid-sparing for Uveitis Trial

Overview

The ADVISE Trial is a randomised, parallel-treatment, comparative effectiveness trial.

It aims to compare the relative effectiveness of adalimumab compared to conventional immunosuppression at controlling ocular inflammation caused by uveitis, while permitting tapering and discontinuation of oral corticosteroids.

  • Principal Investigator
Professor Lyndell Lim

Learn more

View this study at ClinicalTrials.gov

This international database listing provides more detailed information about this study.

Read More

Related Pages

Clinical trials

Refer a patient

We welcome referrals from healthcare practitioners of patients who may be suitable for a clinical trial at Cerulea.

Clinical trials

Register your interest in clinical trials

To express interest in taking part in current or future clinical trials at Cerulea, please join our online database below. First, here are some important things you need to know.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.